FAS and breast carcinoma: To correlate proteomic-based target identification and in silico results with the antitumor activity highlighted by in vitro experiments, we analyzed the regulation of FAS enzymatic activity by MA in protein extracts obtained from MCF-7 and MDA.MB-231 breast cancer cells.